Skip to main content
logo
Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.8419
+0.0099 (1.19%)
Jan 22, 2026, 4:00 PM EST - Market closed

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Novel Synthetic Lethality-based Cancer Therapeutics
1.50M
Log In
Novel Synthetic Lethality-based Cancer Therapeutics Growth
157.63%
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Sweden
1.50M
Log In
Sweden Growth
157.63%
Log In